Author

Y. Liu

Observed names: Y Liu, Yuan Liu

Institution: Emory University

Observed institutions: Emory University, Winship Cancer Institute, Denovo Biopharma LLC (United States)

ORCID: 0000-0001-8926-3058

Observed ORCID: 0000-0001-8926-3058

OpenAlex ID: A5069287677

Comparison of preoperative versus postoperative transversus abdominis plane and rectus sheath block in patients undergoing minimally invasive colorectal surgery

2019 · J. Xia, T. J. Paul Olson, et al. · Colorectal Disease · 12

Clinical outcomes of lutetium-177–PSMA-617 in a racially diverse cohort of patients with metastatic castration-resistant prostate cancer

2026 · Margo Brooke Gerke, Akshay Bedmutha, et al. · The Oncologist · 1

Phase Iii Randomized Study of Enzastaurin/r‐chop Vs Placebo/r‐chop in Frontline High Risk Diffuse Large B Cell Lymphoma Patients With Genomic Biomarker Dgm1 (engine Study)

2019 · J. Zhu, Y. Song, et al. · Hematological Oncology

Abdominal wall mixed malignant germ cell tumor: a case report and review of literature.

2018 · M L Wei, J T Fan, et al. · PubMed

The Addition of Chemotherapy to Radical Prostatectomy for Management of High-Risk Prostate Cancer: A National Cancer Database Analysis

2017 · M.J. Ferris, Y. Liu, et al. · International Journal of Radiation Oncology*Biology*Physics

Predictors of Local Recurrence in Patients With Advanced-Stage Diffuse Large B-Cell Lymphoma (DLBCL) Treated With Rituximab-Based Chemotherapy Alone: Guiding Decisions for Consolidative Radiation Therapy

2014 · N. Jegadeesh, N. Esiashvili, et al. · International Journal of Radiation Oncology*Biology*Physics

Works count: 6

Citation count: 13

H-index: 1

I10-index: 1